The Australian: Race Oncology bolsters leadership with key appointment
As seen in The Australian, Dr Megan Baldwin joins the Race board as Non-Executive Director. Dr Baldwin is a seasoned biotech executive with more than 25 years of experience. She is the Founder and Chief Innovation Officer at Opthea Limited (ASX:OPT; NASDAQ:OPT), a late-stage biopharmaceutical company developing a novel therapy to address the unmet need in the treatment of retinal eye diseases.
Read the full report via this link.